What SOPHiA GENETICS SA's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 40 | 150 |
| Total trades | 43 | 172 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 172 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Xu Zhenyu | Chief Scientific Officer | Oct 13 | Disclosed 10b5-1 sale · S | −4,000 | $7.18 | −$28.7K | 541,493 |
| Camblong Jurgi | Executive Chairman | Oct 12 | Disclosed 10b5-1 sale · S | −8,500 | $7.26 | −$61.7K | 3,387,150 |
| Menu Philippe | Chief Medical Officer | Oct 12 | Disclosed 10b5-1 sale · S | −5,000 | $7.26 | −$36.3K | 195,993 |
| Valente Manuela | Chief People Officer | Oct 05 | Sale for tax withholding · S | −4,240 | $8.13 | −$34.5K | 206,210 |
| Cardoza George | Chief Financial Officer | Oct 05 | Sale for tax withholding · S | −1,592 | $8.10 | −$12.9K | 306,726 |
| Menu Philippe | Chief Medical Officer | Oct 05 | Sale for tax withholding · S | −7,394 | $8.13 | −$60.1K | 200,993 |
| Puylaert Kevin | Chief Sales Officer | Oct 05 | Sale for tax withholding · S | −31 | $7.92 | −$246 | 147,732 |
| Puylaert Kevin | Chief Sales Officer | Oct 05 | Sale for tax withholding · S | −185 | $8.06 | −$1.49K | 147,763 |
| Van Well Daan | Chief Legal Officer | Oct 05 | Sale for tax withholding · S | −6,168 | $8.12 | −$50.1K | 332,716 |
| Xu Zhenyu | Chief Scientific Officer | Oct 05 | Sale for tax withholding · S | −7,394 | $8.12 | −$60.1K | 545,493 |
| Verma Abhimanyu | Chief Technology Officer | Oct 05 | Sale for tax withholding · S | −5,284 | $8.12 | −$42.9K | 166,887 |
| Muken Ross | Chief Executive Officer | Oct 05 | Sale for tax withholding · S | −9,838 | $8.13 | −$80K | 660,391 |
| Camblong Jurgi | Executive Chairman | Oct 05 | Sale for tax withholding · S | −40,172 | $8.13 | −$327K | 3,395,650 |
| Muken Ross | Chief Executive Officer | Sep 21 | Sale for tax withholding · S | −422 | $8.33 | −$3.52K | 670,229 |
| Cardoza George | Chief Financial Officer | Sep 21 | Sale for tax withholding · S | −774 | $8.33 | −$6.45K | 308,318 |
| Menu Philippe | Chief Medical Officer | Sep 14 | Disclosed 10b5-1 sale · S | −5,000 | $7.88 | −$39.4K | 208,387 |
| Xu Zhenyu | Chief Scientific Officer | Sep 14 | Disclosed 10b5-1 sale · S | −4,000 | $7.88 | −$31.5K | 552,887 |
| Van Well Daan | Chief Legal Officer | Sep 11 | Disclosed 10b5-1 sale · S | −6,168 | $7.63 | −$47.1K | 338,884 |
| Camblong Jurgi | Executive Chairman | Sep 10 | Disclosed 10b5-1 sale · S | −8,500 | $7.66 | −$65.1K | 3,435,822 |
| Hibbs Kathy L | Director | Sep 08 | Disclosed 10b5-1 sale · S | −6,250 | $8.13 | −$50.8K | 96,992 |
Loading...
